1st AI-enabled radiation reduction solution for X-rays cleared by FDA

Omega Medical Imaging’s FluoroShield gained FDA clearance this month, becoming the first AI-enabled radiation reduction technology to hit the market.

According to Omega, the FluoroShield—a region of interest radiation exposure reduction solution for interventional X-ray imaging—is powered by a combination of AI, an ultrafast collimator and advanced image processing. In testing, it’s reduced radiation by as much as 84%.

The approach minimizes radiation doses to both patients and nearby staff, and Omega’s site states it “seamlessly helps you reach your ALARA (as low as reasonably achievable) goals.”

Right now, FluoroShield is only compatible with Omega’s Flat Panel detector CS-series product lines.

""

After graduating from Indiana University-Bloomington with a bachelor’s in journalism, Anicka joined TriMed’s Chicago team in 2017 covering cardiology. Close to her heart is long-form journalism, Pilot G-2 pens, dark chocolate and her dog Harper Lee.

Around the web

A string of executive orders from the White House created serious concerns among radiologists and other healthcare providers throughout the United States. The American College of Radiology issued a statement to help guide its members through the chaos. 

Bridgefield Capital, founded in 2015, has previously invested in such popular brands as Cirque Du Soleil, Del Monte and Quiksilver. This transaction is expected to be completed in the second half of 2025. 

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it.